Experience of low dose magnesium Sulphate for the management of Eclampsia and its comparison with Pritchard regime
Abstract
Objectives: To study the effectiveness, side effects, maternal and perinatal outcome, using low dose Magnesium sulphate and to compare the results with Pritchard regime.
Methods: Thirty women with eclampsia aged between 25 to 35 years were prospectively studied over two years at M.G.M hospital & research center, Patna, Bihar. Study was designed into Group A who received low dose magnesium sulphate regime (n=15) and Group B who received standard Pritchard regime (n=15).
Results: Groups were compared with respect to type of eclampsia, amount of dose of Magnesium sulphate and Signs of Toxicity of Magnesium sulphate. Magnesium sulphate received was 23gm in Group A and 44 gms in Group B and dose related toxicity was less in Group A. Perinatal morbidity and mortality was higher with Pritchard regime compared to low dose Magnesium sulphate regime.
Conclusion: Low dose Magnesium sulphate is as effective as conventional full dose Pritchard regime with lesser side effects with equally good perinatal outcome.
Downloads
References
Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimes for women with pre-eclampsia and eclampsia. Cochrane Database System rev 2010(8): CD00738.
Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992 Jul;99(7):547-53.
Shamsuddin L, Nahar K, Nasrin B, Nahar S, Tamanna S, Kabir RM et al. Use of parenteral magnesium sulphate in eclampsia and severe pre-eclampsia cases in a rural set up of Bangladesh. Bangladesh Med Res Counc Bull. 2005; 31(2): 75-82.
Mayes M, Sweet BR, Tiran D: Maye's Midwifery- A textbook for Midwives London, Bailliere Tindall, 1997, pp 533-545.
Bhargava A, Pant R, Chutani I, Singh SK : In search for accelerated recovery from eclampsia. J Obstet Gynecol India 2006; 56:402-405.
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995:345 (8963):1455-63.
Shilva, Saha SC, Kalra J, Prasad R. Safety and efficancy of low dose Magnesium sulphate in the treatment of Eclampsia. Int J Gynaecol Obstet. 2007 May;97(2):150-1. Epub 2007 Mar 21.
Witlin AG. Prevention and treatment of eclamptic convulsions. Clin Obstet gnyecol 1999;42 (3) : 507–18.
Idama TO, Lindow SW. Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. Br J Obstet Gynecol 1998;105 (3):260–8.
Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose ("Dhaka") magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand. 2001; 80 (11): 998–1002.
Mahajan NN, Thomos A, Soni RN, Gaikwad NL, Jain SM. 'Padhar Regime' - a low dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest. 2009;67(1):20-4. doi: https://doi.org/10.1159/000158647. Epub 2008 Sep 30.
Pritchard JA. The use of magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet. 1955 Feb;100(2):131-40.
Flower CA. Magnesium sulphate in toxemia of pregnancy-New dosage schedule based on body weight. Obstet Gynecol. 1962 Mar;19:315-27.
Sardesai S, Maira S, Patil A et al. Low dose Magnesium Sulphate therapy for eclampsia and imminent eclampsia Regime tailored for indian women. J Obstet Gynecol India 2003; 53–6:546–550.
Phusapradit W, Saropala N, Haruvasin S, Thuvasethakul P. Serum level of magnesium attained in magnesium sulphate therapy for severe preeclampsia. Asia Oceania J Obstet Gynecol. 1993; 19(4): 387–90.
Helmin RHJ. Prevention of eclampsia and pre-eclampsia. Lancet. 1952; 1:64-8.
Maternal anthropometry and pregnancy outcomes. A WHO Collaborative Study. Bull world Health Organ. 1995; 73 (Suppl): 1-98.
El-Nafaty AU, Melah GS, Massa AA, Audu BM, Nelda M. The analysis of eclamptic morbidity and mortality in the specialist Hospital Gombe, Nigeria. J Obstet Gynocol. 2004;24(2):142–7.
Ekele BA, Ahmed Y. Magnesium sulfate regimens for eclampsia. Int J Gynecol Obstet. 2004; 87(2): 149–50.
Guzman ER, Conley M, Stewart R, Ivan J, Pitter M, Kappy K. Phenytoin and magnesium sulphate effects on fetal heart rate tracing assessed by computer analysis. Obstet Gynecol. 1993; 82(3):375–379.
Atkinson MW, Belfort MA, Sadde GR, Moise KJ. The relation between magnesium sulphate therapy and fetal heart rate variability. Obstet Gynecol 1994; 83:967–70.
OAI - Open Archives Initiative
